Avantor ( (AVTR) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Avantor’s stock is on the rise following Raymond James’ decision to increase the company’s price target. This adjustment comes as a result of anticipated slower recovery in end markets, which aligns with Avantor’s commentary and investor expectations. Additionally, Avantor’s strategic partnership with BlueWhale Bio to enhance immune cell therapy manufacturing is seen as a positive move, potentially expanding patient access and manufacturing capacity. These developments highlight Avantor’s strong market positioning and strategic growth initiatives.
More about Avantor
YTD Price Performance: -34.58%
Average Trading Volume: 12,062,966
Technical Sentiment Signal: Sell
Current Market Cap: $9.46B
For further insights into AVTR stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.